Overview & Mechanism
A small peptide designed from Cerebrolysin that promotes neurogenesis and synaptic plasticity, improving cognitive outcomes in animal models.
Research Dosage
0.5–1 mg/day (research)
Subcutaneous injection
Once daily
2–4 weeks
Reconstitution & Storage
Reconstitute per vial concentration with bacteriostatic water.
Lyophilized: −20 °C. Reconstituted: refrigerate 2–8 °C.
Safety & Side Effects
Early-stage research compound with limited human data.
Studies
P21 and neurogenesis
P21 stimulated neurogenesis and improved cognitive function in animal models, suggesting potential for neurodegenerative conditions.
Read studyReferences
Research Use Only
This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.